170 related articles for article (PubMed ID: 27456016)
1. Prognosis of Fibrolamellar Carcinoma Compared to Non-cirrhotic Conventional Hepatocellular Carcinoma.
Yamashita S; Vauthey JN; Kaseb AO; Aloia TA; Conrad C; Hassan MM; Passot G; Raghav KP; Shama MA; Chun YS
J Gastrointest Surg; 2016 Oct; 20(10):1725-31. PubMed ID: 27456016
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the American Joint Committee on Cancer (AJCC) 8th Edition Staging System for Hepatocellular Carcinoma in 1,008 Patients with Curative Resection.
Park S; Choi S; Cho YA; Sinn DH; Kim JM; Park CK; Ha SY
Cancer Res Treat; 2020 Oct; 52(4):1145-1152. PubMed ID: 32599989
[TBL] [Abstract][Full Text] [Related]
3. Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): A Surveillance, Epidemiology, End Results (SEER) analysis.
Kamarajah SK; Frankel TL; Sonnenday C; Cho CS; Nathan H
J Surg Oncol; 2018 Mar; 117(4):644-650. PubMed ID: 29127719
[TBL] [Abstract][Full Text] [Related]
4. Importance of tumor size as a prognostic factor after partial liver resection for solitary hepatocellular carcinoma: Implications on the current AJCC staging system.
Goh BK; Teo JY; Chan CY; Lee SY; Jeyaraj P; Cheow PC; Chow PK; Ooi LL; Chung AY
J Surg Oncol; 2016 Jan; 113(1):89-93. PubMed ID: 26611492
[TBL] [Abstract][Full Text] [Related]
5. Liver resection for hepatocellular and fibrolamellar carcinoma in a South African tertiary referral centre - an observational cohort analysis.
Ziaei Y; Krige JEJ; Jonas EG; Kotze UK; Bernon MM; Kloppers C; Sobnach S
S Afr J Surg; 2024 May; 62(2):13-17. PubMed ID: 38838113
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for survival after hepatic resection of early hepatocellular carcinoma in HBV-related cirrhotic patients.
Zhu Q; Yuan B; Qiao GL; Yan JJ; Li Y; Duan R; Yan YQ
Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):418-27. PubMed ID: 26823044
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma.
Chun YH; Kim SU; Park JY; Kim DY; Han KH; Chon CY; Kim BK; Choi GH; Kim KS; Choi JS; Ahn SH
Eur J Cancer; 2011 Nov; 47(17):2568-75. PubMed ID: 21835608
[TBL] [Abstract][Full Text] [Related]
8. The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis.
Ha SY; Kim JH; Yang JW; Kim J; Kim B; Park CK
Cancer Res Treat; 2016 Jul; 48(3):1065-73. PubMed ID: 26511806
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the seventh edition of the American Joint Committee on Cancer tumour-node-metastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: implications for the development of a refined staging system.
Chan AC; Fan ST; Poon RT; Cheung TT; Chok KS; Chan SC; Lo CM
HPB (Oxford); 2013 Jun; 15(6):439-48. PubMed ID: 23659567
[TBL] [Abstract][Full Text] [Related]
10. The prognosis of fibrolamellar carcinoma versus conventional hepatocellular carcinoma: a study based on propensity score matching.
Qiu S; Chen R; Hu J; Han T
Scand J Gastroenterol; 2023; 58(11):1351-1358. PubMed ID: 37353942
[TBL] [Abstract][Full Text] [Related]
11. Fibrolamellar hepatocellular carcinoma at a tertiary centre in South Africa: a case series.
Bhaijee F; Locketz ML; Krige JE
S Afr J Surg; 2009 Nov; 47(4):108-11. PubMed ID: 20141066
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment.
Vauthey JN; Ribero D; Abdalla EK; Jonas S; Bharat A; Schumacher G; Lerut J; Chapman WC; Hemming AW; Neuhaus P
J Am Coll Surg; 2007 May; 204(5):1016-27; discussion 1027-8. PubMed ID: 17481532
[TBL] [Abstract][Full Text] [Related]
13. Validation of the American Joint Committee on Cancer eighth edition staging system in patients undergoing hepatectomy for hepatocellular carcinoma: a US population-based study.
Zhang G; Li R; Zhao X; Meng S; Ye J; Zhao L
J Surg Res; 2018 Feb; 222():55-68. PubMed ID: 29273376
[TBL] [Abstract][Full Text] [Related]
14. Systematic review of outcomes and meta-analysis of risk factors for prognosis after liver resection for hepatocellular carcinoma without cirrhosis.
Xie QS; Chen ZX; Zhao YJ; Gu H; Geng XP; Liu FB
Asian J Surg; 2021 Jan; 44(1):36-45. PubMed ID: 32988708
[TBL] [Abstract][Full Text] [Related]
15. Number of nodules, Child-Pugh status, margin positivity, and microvascular invasion, but not tumor size, are prognostic factors of survival after liver resection for multifocal hepatocellular carcinoma.
Goh BK; Chow PK; Teo JY; Wong JS; Chan CY; Cheow PC; Chung AY; Ooi LL
J Gastrointest Surg; 2014 Aug; 18(8):1477-85. PubMed ID: 24855028
[TBL] [Abstract][Full Text] [Related]
16. The prognosis and survival analysis according to seven staging systems of hepatocellular carcinoma following curative resection.
Choi SB; Lee JG; Kim KS; Yoon DS; Choi JS; Lee WJ; Kim BR
Hepatogastroenterology; 2008; 55(88):2140-5. PubMed ID: 19260493
[TBL] [Abstract][Full Text] [Related]
17. Which factors affect the long-term survival of patients with hepatocellular carcinoma UICC stage IV?
Bauschke A; Altendorf-Hofmann A; Malessa C; Schüle S; Zanow J; Settmacher U
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2593-2601. PubMed ID: 27630023
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma.
Lei HJ; Chau GY; Lui WY; Tsay SH; King KL; Loong CC; Wu CW
J Am Coll Surg; 2006 Oct; 203(4):426-35. PubMed ID: 17000385
[TBL] [Abstract][Full Text] [Related]
19. Impact of histologically confirmed lymph node metastases on patient survival after surgical resection for hepatocellular carcinoma: report of a Japanese nationwide survey.
Hasegawa K; Makuuchi M; Kokudo N; Izumi N; Ichida T; Kudo M; Ku Y; Sakamoto M; Nakashima O; Matsui O; Matsuyama Y;
Ann Surg; 2014 Jan; 259(1):166-70. PubMed ID: 23532111
[TBL] [Abstract][Full Text] [Related]
20. Impact of perioperative allogeneic blood transfusion on the long-term prognosis of patients with different stage tumors after radical resection for hepatocellular carcinoma.
Peng T; Wang L; Cui H; Li X; Liu M; Yu J; Wu J; Zhao G; Liu Z
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):620-627. PubMed ID: 32988700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
